Longitudinal dimensionality of adolescent psychopathology: Testing the differentiation hypothesis by Sterba, Sonya K. et al.
Longitudinal dimensionality of adolescent psychopathology:
Testing the differentiation hypothesis
Sonya K. Sterba1, William Copeland2, Helen Link Egger2, E. Jane Costello2, Alaattin
Erkanli2, and Adrian Angold2
1Department of Psychology, University of North Carolina at Chapel Hill
2Center for Developmental Epidemiology, Department of Psychiatry, Duke University
Abstract
Background—The differentiation hypothesis posits that the underlying liability distribution for
psychopathology is of low dimensionality in young children, inflating diagnostic comorbidity
rates, but increases in dimensionality with age. This hypothesis not been adequately tested with
longitudinal psychiatric symptom data.
Methods—Confirmatory factor analyses of DSM-IV symptoms from seven common Axis I
syndromes—major depression (MDD), generalized anxiety (GAD), separation anxiety (SAD),
social anxiety (SOC), attention deficient hyperactivity disorder (ADHD), conduct disorder (CD)
and oppositional defiant disorder (ODD) were conducted longitudinally, from ages 9–16, in the
general-population Great Smoky Mountains Study sample.
Results—An eight syndrome model fit well at all ages: CD, ODD, SAD, SOC, multidimensional
ADHD (hyperactivity, impulsivity, and inattention) and unidimensional MDD/GAD. A high
degree of measurement invariance was found for all syndromes except for MDD/GAD. MDD and
GAD syndromes slightly diverged at age 14–16, when they also began to explain more symptom
variance. Additionally, correlations between some emotional and disruptive syndromes showed
slight differentiation.
Conclusions—Marked developmental differentiation of psychopathology, as implied by the
orthogenetic principle, is not a prominent cause of preadolescent and adolescent psychiatric
comorbidity.
Many competing explanations for child and adolescent psychiatric comorbidity (e.g. Caron
& Rutter, 1991), have been empirically investigated (e.g. Angold, Costello, & Erkanli, 1999;
Krueger & Markon, 2006), but one persisting explanation has not. This explanation contends
on developmental-theoretical grounds that psychiatric disorders become differentiated from
one another with advancing age, such that at younger ages the underlying liability
distribution for psychopathology is of lower dimensionality (Lahey et al., 2004; Lilienfeld,
Waldman & Israel, 1994; Patterson, 1993). Imposing age-invariant diagnostic cutpoints
upon an underlying distribution of lower dimensionality induces artifactual psychiatric
comorbidity. As articulated by Lilienfeld et al. (1994) this differentiation hypothesis states
that:
“children with comorbid syndromes may be at a stage in which the different
developmental processes underlying these syndromes have yet to achieve full
differentiation. A failure to appreciate the implications of the orthogenetic principle
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may partially explain the particularly high rates of comorbidity among many
childhood disorders” (p. 77).
Although the dimensionality of multiple common Diagnostic and Statistical Manual (DSM-
IV) syndromes has been tested in cross-sectional, general population samples by factor
analyzing DSM symptoms (see Table 1), this evidence cannot be used to adequately test the
differentiation hypothesis for several reasons. First, comparisons of DSM syndrome
differentiation have only been made between-children, across-age, not within-child, across
age. Second, between-children, across-age comparisons are complicated by the fact that
most studies report syndrome correlations only for markedly age-heterogeneous samples
(e.g., 3–19). Third, although some studies have reported syndrome correlations for more
homogeneous subgroups—preschoolers (2–5) or pre-adolescents and adolescents (11–19)—
the latent syndrome correlations between-study, within-agegroup can be as large or larger
than those within-study, across-agegroup, and, moreover, latent syndrome correlations are
never accompanied by confidence intervals to facilitate across-study comparison.
Nevertheless, piecing together the available evidence (putting aside potential informant
biases, based on results of Lahey et al., 2004; 2008) there appears, at first, to be some
evidence of changing syndrome dimensionality between preschool-age and preadolescence,
particularly among disruptive disorders. That is, unlike in preadolescents and adolescents,
Sterba, Angold, and Egger (2007a) found oppositional defiant disorder (ODD) and conduct
disorder (CD) to be unidimensional in preschoolers and Bauermeister (1992) found
subfactors of attention deficit hyperactivity disorder (ADHD)—hyperactivity (H),
impulsivity (IN), inattention (I)—to be unidimensional in preschoolers and Sterba et al.
(2007a) found them nearly unidimensional (see Table 1). Additionally, among younger (4–
10) but not older (11–17) children Lahey et al. (2004) found ODD and HI unidimensional,
but differentiable from CD and IN (correlations only reported for age 4–17; see Table 1
footnote). However, such developmental changes in syndrome dimensionality actually
represent only a trivial amount of differentiation; Table 1 shows that, among preadolescent-
and/or adolescent-only samples, ODD and CD have been found related at most at r=.91, and
HI and IN have been found related at most at r=.85, and HI and ODD have been found
related at most r=.87. Even less evidence exists in Table 1 for developmental differentiation
among emotional syndromes from preschool to preadolescence. Common emotional
syndromes were either consistently differentiable across agegroups (separation anxiety
disorder, SAD, and social phobia, SOC), or consistently undifferentiable across agegroups
(major depression, MDD, and generalized anxiety disorder, GAD, except in Hartman et al.,
2001). In fact, the only syndrome correlations in Table 1 which were consistently higher in
preschoolers versus (pre)-adolescent or older samples by a clinically-meaningful margin
(e.g. r≥.100 involved relations of emotional syndromes (mainly MDD, GAD) to disruptive
syndromes (H, I, IN, CD, ODD).
However, these summary remarks are preliminary because they (a) do not account for
within-study sampling variability in syndrome correlations, (b) use between-child syndrome
differences to make inferences about within-child syndrome change, and (c) generalize
across studies that vary considerably regarding specificity and comprehensiveness of
symptom measurement and regarding accommodation of overlapping symptoms. Still, Table
1 shows that we know even less about whether syndrome differentiation continues across
preadolescence to adolescence than we do about syndrome dimensionality change from
preschool to preadolescence. No studies compared syndrome dimensionality across
preadolescents, early adolescents, and later adolescents. Particularly relevant to DSM-V is
whether GAD and MDD differentiate in adolescence (Moffitt et al., 2007; Greenberg, 2008),
a time known to be critical for the emergence and organization of depression (Angold,
1988). This study overcomes these limitations in examining the dimensionality of common
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Axis I syndromes (MDD, GAD, ODD, CD, ADHD, SAD, SOC) across age 9–16 in a
longitudinal general-population probability sample, and provides the first inferential test of
the differentiation hypothesis in this setting.
Methods
Participants
Data were drawn from the Great Smoky Mountains Study (GSMS). See Costello et al.,
(1996) for study details. A representative sample of 4,500 children, aged 9, 11, and 13, were
drawn from a finite population of 12,000 in 11 western North Carolina counties using a
household equal-probability accelerated-cohort design. Parent-reported behavioral problem
screenings were obtained from 95% of this stage 1 sample. At stage 2, all American Indian
youth were recruited (n=450), along with all screen-high children and 10% of screen-low
children (total N=1420; 44% girls, 56% boys). Present analyses were based on data from
when children were 9–16 (first eight annual waves of assessment). Sampling weights
accounted for unequal probabilities of selection in all analyses. Re-weighted demographics
indicated 89.4% of recruited participants were Caucasian, 6.9% were African American, and
3.7% were American Indian. An average response rate of 83% was maintained across waves
included in these analyses (range 75–94%). Sampling weights were adjusted for
nonresponse at wave 1. Estimation methods employed for binary indicators only
accommodated pairwise deletion of missing data under MCAR; (multiple imputation is
problematic for sparse binary data; Allison, 2007). Cohort differences were examined in
Sterba et al., (2007b), but not found; present analyses do not control for cohort.
Measures
At each wave, the child and primary caregiver (usually mother) were separately interviewed
using the Child and Adolescent Psychiatric Assessment (CAPA; Angold, et al., 1995). The
CAPA is an interviewer-based interview which uses structured questioning to gather onset,
intensity, frequency and duration information on symptoms described in an extensive
glossary, across a 3-month reference period. Computerized algorithms determined whether
symptoms meet endorsement criteria operationalized in the DSM-IV. Child and parent
reports were combined using the standard `or' rule (Costello et al., 1996)—except in the case
of ADHD, where standard practice dictated sole reliance on parent report (Angold et al.,
1995). CAPA symptom intra-class correlations ranged from .50 (ODD) to .88 (MDD)
(Angold et al., 1995).
Statistical Analysis
Modeling framework—Traditional methods for testing factor structure stability over time
—longitudinal factor analysis—cannot simultaneously handle 7 factors (and 66 relatively-
sparse binary items) at each of 8 measurement occasions (56 factors total). Instead, we
estimated our multi-syndrome model at three condensed age blocks: ages 9–10, 11–13, and
14–16. (Alternative age groupings were tried but did not materially alter results; Sterba et
al., 2007b). The number of observations per agegroup were: N=936 for age 9–10, N=2588
for age 11–13, N=3150 for age 14–16. Thus, within each agegroup's factor model, we have
up to three observations nested within-child; this dependency is accounted for by adjusting
standard error and chi square computations using TYPE=COMPLEX in Mplus 5.0. Fitting
factor models separately for 9–10 year-olds, 11–13 year-olds, and 14–16 year-olds
complicated comparison of factor loadings and factor correlations across agegroups. To
illustrate our approach, consider the comparison of a single factor loading at age 9–10 versus
age 11–13. Given the estimate and standard error of that particular factor loading at age 9–
10, we used parametric bootstrapping (10,000 resamples) to generate its Monte Carlo
sampling distribution at age 9–10, and similarly used parametric bootstrapping to generate
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its Monte Carlo sampling distribution at age 11–13. From these two sampling distributions,
we created a sampling distribution of the across-agegroup differences in that loading. The
100(α/2)th and 100(1 − α /2)th percentile values from that sorted bootstrap sampling
distribution of differences served as the lower and upper bounds of a 100(1 − α)%
confidence interval for the across-agegroup difference in that factor loading, which was used
to test the null that the difference between the two loadings is 0 in the population. The same
procedure was repeated for all factor loadings, for all three agegroup comparisons (i.e. 9–10
vs. 11–13; 11–13 vs. 14–16; 9–10 vs. 14–16). A similar procedure was used to compare
factor correlations across agegroups, with the following caveats. Instead of simply using the
estimated r and its SE to generate bootstrap resamples, first, Fisher's r to z' transformation
was first used to transform the estimated r to an approximately-normal metric, and, second,
confidence bounds of the original correlation were transformed and used to derive its
transformed SE. The transformed r and transformed SE were then used to generate bootstrap
resamples, creating sampling distribution of the transformed r; the transformed rs were back-
transformed to create sampling distributions of rs.
Model specification—All models contained all syndromes under investigation (ODD,
CD, ADHD, MDD, SAD, GAD, SOC) so as not to incur omitted syndrome bias (Angold et
al., 1999) in determining dimensionality. All DSM symptoms were allowed to load on their
corresponding latent syndrome factor, with the exception of the following symptoms that
were never endorsed: ADHD9 (forgetting), CD4 (human cruelty), CD6 (confrontational
stealing), CD14 (runs away), at age 9–10; and ADHD9 (forgetting) at age 11–13. Within
age-block, competing CFA models were inferentially compared to test for developmental
changes in dimensionality of specific syndromes: MDD and GAD; ODD and CD; H, I, and
IN; H and ODD, adjusting for all other disorders. Across age-block, final correlated-
syndromes models were compared for evidence of across-time syndrome differentiation,
particularly between emotional and disruptive syndromes.
Symptoms shared across syndromes can artificially inflate the magnitude of syndrome
covariation (Angold et al., 1999; Lilienfeld et al., 1994). Hence, item-specific residuals of
overlapping symptoms were allowed to correlate: (a) irritability (ODD, GAD, MDD) (b) too
little/much sleep (GAD, MDD) (c) school refusal/absence (SAD, CD) and (d) lying/blaming
(CD, ODD). The fatigue symptom for GAD and MDD was correlated >.95; to prevent
collinearity, it was combined into a single, cross-loading indicator. In other cases, a single
symptom from one DSM syndrome related to a set of symptoms from another syndrome. To
capture this, that symptom was allowed to cross-load: the concentration symptoms of GAD
and MDD cross loaded on Inattention and restless/keyed up symptom of GAD cross loaded
Hyperactivity (following Hartman et al., 2001).
Model Estimation—Robust weighted least squares with tetrachoric correlation input and
adjustments for nonnormality and nonindependence was used for estimation (WLSMV;
Mplus 5.0, Muthén & Muthén, 1998–2008). As a result of low endorsement rates, several
symptoms belonging to the same disorder were parceled (summed) into one indicator to
avoid estimation problems. At age 9–10, MDD 2,5,1 (anhedonia, psychomotor agitation/
retardation, depressed/irritable), were parceled; ADHD 5,7 (unorganized, loses things) were
parceled, and CD 5,7 (animal cruelty, forced sex) were parceled; at age 11–12, CD 4,5,6,7
(animal/human cruelty, confrontational stealing, forced sex) and CD 13,14 (breaks curfew,
runs away) were parceled; at age 14–16 only CD 4,5,6,7 were parceled. Sensitivity analyses
indicated that the 1–2 parcels/factor did not change dimensionality results.
Model evaluation—For assessing model fit, we used RMSEA (population misfit per
degree of freedom; ≤.05 indicates good fit) and CFI (fit relative to a null baseline; ≥.95
indicates good fit) which are relatively insensitive to N (Yu, 2002). For model comparisons,
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we used Robust Δχ2, which is sensitive to N, and we reran models with Robust-Maximum
Likelihood to obtain BIC and sample size adjusted BIC, which penalize for model
complexity (lower BIC is better).
Results
Within-age-block: Testing syndrome dimensionality
Dimensionality testing via model comparisons #1–#5 in Table 2 resulted in eight-factor final
models (MDD/GAD, SAD, ODD, CD, SOC, Hyperactivity, Impulsivity, Inattention) with
good fit at each age-block. For 9–10, RMSEA=.03 and CFI=.94; for 11–13, RMSEA=.02
and CFI=.98; for 14–16, RMSEA=.02 and CFI=.97. In model comparison #1, specifying
MDD and GAD as separate factors resulted at age 9–10 and 11–13 in a linear dependence
between MDD and GAD (r≥.00), indicating separate dimensions were not supported (Lahey
et al., 2008 used similar procedures). BIC showed worse fit for separate GAD and MDD
factors at 9–10, and essentially unchanged fit for separate GAD and MDD at 11–13. At age
14–16, the correlation between MDD and GAD was r=.90, which was statistically
differentiable according to χ2 and BIC. Despite some slight indication of a dimensionality
change, from uni-to near-unidimensional, we retained GAD and MDD as unidimensional in
final models. In model comparison #2, ODD and CD were found to be statistically distinct at
all ages according to χ2, after adjusting for other disorders, yet separating them sizably
improved the BIC only at age 14–16. On balance, most of this mixed evidence supported
ODD and CD as separate factors across-age. In model comparison #3, at all agegroups, χ2
and BIC identified a significant decrement in fit from collapsing a trifactorial (I, H, IN)
model for ADHD into a unifactorial model, and model comparison #4 identified a smaller,
but significant, decrement from collapsing a trifactorial model to a bifactorial (HI, IN)
model. A trifactorial ADHD specification was retained for all age groups. Finally, model
comparison #5 indicated that ODD and H were always statistically distinct according to χ2
and BIC.
Across-age-block: Testing the differentiation hypothesis
Across-age invariance testing involved first testing for configural invariance, then metric
invariance, then factor correlation invariance. (Note that symptom thresholds cannot be
tested for across-age invariance with binary data.) Table 3 shows that configural invariance
(same pattern of significant and non-significant loadings across age) was partially met for
factor loadings in final models. All but three symptoms showed positive, significant
loadings on their designated DSM syndromes at each agegroup. The three age-variant
symptoms were those that were allowed to cross-load on multiple factors to prevent
artifactual inflation of factor correlation estimates. The primary loading of MDD8
(concentration) was age-invariant, but its secondary loading was not, whereas, the secondary
loadings of GAD1 (restlessness) and GAD3 (concentration) were age-invariant, but their
primary loadings were not. Table 3 also shows that the more stringent metric invariance
(same loading magnitude across age) was partially met for factor loadings in final models.
Most of the across-age loading differences were found for MDD/GAD, where some loadings
increased at age 14–16. No MDD/GAD loadings significantly changed magnitude between
9–10 and 11–13. This finding is also reflected in Table 4, where the average proportion of
variance in DSM symptoms explained by their designated DSM syndromes remained
predominantly stable across-ages for most syndromes, but increases at age 14–16 for MDD/
GAD. Finally, Table 5 shows that most factor correlations were not significantly different
across-agegroups, and factor correlations had sizable sampling variability (large 95% CIs).
Disruptive syndromes were most highly correlated with each other across-age, as were
emotional syndromes—with the exception of MDD/GAD, which sometimes associated
more strongly with disruptive syndromes. When factor correlations changed significantly
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across-agegroups, it almost always happened in early adolescence (i.e. 9–10 vs. 11–13 or 9–
10 vs. 14–16, but not 11–13 vs. 14–16), involved instable, low correlations between
emotional and disruptive syndromes, and did not represent a consistent pattern of
differentiation. For example, whereas SOC and MDD/GAD became less correlated with CD
by age 14–16, SAD became more correlated with I, H, IN and ODD by age 14–16.
Discussion
This study represents the first inferential test of the differentiation hypothesis across the
transition to adolescence using diagnostic-interview symptom data from multiple syndromes
in a general-population sample.
Overall, primarily the same number of dimensions (eight) was identified as well-fitting for
all age-groups: H, IN, I, ODD, CD, SAD, SOC, and MDD/GAD. This multi-syndrome
longitudinal factor structure displayed a high degree of measurement invariance: nearly the
same factor loading pattern and factor loading magnitude was found across-age, except for
MDD/GAD. That is, areas of suspected dimensionality change from preschool to
preadolescence (dimensionality of ODD and CD, of H, I, and IN, and of H and ODD;
Bauermeister, 1992; Lahey et al., 2004; Sterba et al., 2007b) showed stable dimensionality
from pre-adolescence to later adolescence (Table 2). But areas of suspected dimensionality
stability from preschool to preadolescence (dimensionality of MDD and GAD; Lahey et al.,
2004, 2008; Sterba et al., 2007b) showed indications of slight differentiation from pre-
adolescence to later adolescence (Table 2). Other indications of this small developmental
shift or reorganization of MDD/GAD starting at age 14–16 were increases in magnitude of
some MDD and GAD symptom loadings at age 14–16 (Table 3), and increases in
proportions of symptom variance accounted for by the MDD/GAD syndrome at age 14–16
(Table 4). Relatedly, some MDD/GAD symptom reorganization between 4–10 vs. 11–17
years was found by Lahey et al., (2004). Yet treating MDD/GAD as unidimensional at age
14–16 still resulted in good model fit.
Moreover, across-age correlations among these eight putative dimensions displayed no
consistent pattern of developmental differentiation. For example, whereas some emotional
syndromes (SOC) became significantly more distinct from disruptive syndromes, others
(SAD) became significantly less distinct from disruptive syndromes. These heterotypic
correlations could temporarily (for one or two agegroups) be very small (< r=.10)—lower
than found in prior studies (see Table 1)—but their 95% CIs usually included values found
in prior studies. The only pattern conceivably interpretable as developmental differentiation,
and in line with prior findings in Table 1, was the consistently decreasing correlations
between MDD/GAD and CD, H, I, and IN (but not ODD); however, these trends were not
statistically significant. Overall, correlations among disruptive syndromes showed greater
stability, and correlations between disruptive and emotional syndromes showed less
stability.
Future CFA studies are needed that compare the dimensionality of MDD and GAD in
adulthood to MDD and GAD in adolescence to (a) clarify whether MDD and GAD indeed
remain at- or near-unidimensional into adulthood, and, (b) clarify whether the GAD
construct displays longitudinal coherence, in light of our inconsistent loadings for two GAD
symptoms (the same inconsistency as was found in Hartman et al., 2001). An essentially-
unidimensional MDD/GAD over time, or an unstable-dimensionality of MDD/GAD over
time has important implications for comorbidity models presently being used to inform
DSM-V (Watson, 2005). These comorbidity models use threshold DSM diagnoses as
indicators of higher-order “core psychopathological constructs.” MDD and GAD diagnoses
are treated as separate indicators, without first establishing distinctness of their liability
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distributions, and higher-order “anxious/misery” or “distress” factors are included to explain
their covariation (e.g. Vollebergh et al., 2001). If MDD and GAD are indeed
unidimensional, such models are misspecified and higher-order anxious/misery or distress
factors simply compensate for this misspecification.
Limitations
Several limitations of this study deserve mention. First, testing competing statistical models
is only one way of examining the longitudinal internal validity of DSM nosology. Second,
barring estimation difficulties with sparse, binary symptom data, testing multi-syndrome
models at all ages simultaneously would have allowed us to quantify decrements in model
fit associated with imposing age-invariance constraints. Third, symptom sparseness even
under the combined-informant `or' rule prohibited splitting analyses by informant, however,
Lahey et al. (2004; 2008) found no important informant (parent versus child) invariance for
similar multi-syndrome models. Fourth, across-gender and across-race comparisons of
syndrome loading and covariation patterns did not yield marked or consistent differences
and so were not presented here.
Conclusions
The kind of marked developmental changes in the structure of psychopathology, from an
undifferentiated “mass” to distinct DSM dimensions, as predicted by the orthogenetic
principle (Lilienfeld et al., 1994), were not supported. Some mild differentiation may occur
early—by preadolescence—among disruptive syndromes, and some mild differentiation
may occur during adolescence, if at all, for GAD and MDD and between some emotional
and disruptive syndromes.
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Table 2





Age 9–10 Age 11–13 Age 14–16
Δ χ2 (df)1 ΔBIC3 Δ χ2 (df)1 ΔBIC3 Δ χ2 (df)1 ΔBIC3
#1 (A) vs. Final -- Δ +9 -- Δ −9 Δ 8.84 (1)** Δ −218
#2 Final vs. (D) Δ 10.94 (1)** Δ −18 Δ 21.99 (1)*** Δ −171 Δ 70.39 (1)*** Δ −624
#3 Final vs. (B) Δ 26.62 (2)*** Δ −1213 Δ 77.71 (3)*** Δ −3908 Δ 81.26 (3)*** Δ −2306
#4 Final vs. (C) Δ 22.50(1)*** Δ −272 Δ 32.71 (1)*** Δ −1491 Δ 30.27 (1)*** Δ −873
#5 Final vs. (E) Δ 40.20 (1)*** Δ −239 Δ 62.84 (1)*** Δ −1163 Δ 100.72 (1)*** Δ −2033
Final model 109.35 (53) *** −26469 169.88 (79)**** −147970 161.98 (78) * −267459
Notes:
-- could not be estimated.
Model A = MDD + GAD + SAD + SOC + ODD + CD + H + I + IN
Model B = MDD/GAD + SAD + SOC + ODD + CD +ADHD
Model C = MDD/GAD + SAD + SOC + ODD + CD + H/I + IN
Model D = MDD/GAD + SAD + SOC + ODD/CD + H + I + IN
Model E = MDD/GAD + SAD + SOC + ODD/H + CD + I + IN








Degrees of freedom for robust chi square tests of absolute fit and difference tests are not determined directly from the model specification, but
estimated (Satterthwaite-type) as described in Muthén (1998–2004; equation 110).
2
The more restrictive model is supported if the chi square difference does not increase appreciably from the less- to more-restrictive model.
3
Same pattern obtained with sample size adjusted BIC.













Sterba et al. Page 12
Table 3
Standardized factor loadings from age 9–10, 11–13, and 14–16 models
Age 9–10 Age 11–13 Age 14–16
Estimate (S.E.) Estimate (S.E.) Estimate (S.E.)
Inattention
Careless_mistakes 0.91 (0.03) 0.93 (0.01) 0.95 (0.02)
Sustaining_attention 0.89 (0.03) 0.94 (0.02) 0.93 (0.02)
Listening 0.97 (0.02) 0.9211/14 (0.02) 0.98 (0.01)
Following_through 0.95 (0.02) 0.94 (0.01) 0.92 (0.02)
Organizing
0.76
a9/11 (0.06) 0.95 (0.04) 0.85 (0.06)
Sustaining_tasks 0.98 (0.03) 0.98 (0.02) 0.95 (0.02)
Loses_things
0.76
a (0.06) 0.85 (0.03) 0.88 (0.03)
Easily_distracted 0.95 (0.02) 0.94 (0.02) 0.94 (0.02)
Forgetful 0.99 (0.03)
GAD3 concentrating 0.95 (0.05) 1.0511/14 (0.03) 0.86 (0.03)
MDD8 concentrating 0.26 (0.13) 0.5211/14 (0.06) 0.15† (0.10)
Hyperactivity
Fidgets 0.87 (0.04) 0.88 (0.02) 0.90 (0.03)
Leaves_seat 0.93 (0.03) 0.94 (0.02) 0.87 (0.05)
Runs/climbs 0.93 (0.03) 0.95 (0.02) 0.95 (0.03)
Quiet_activities 0.96 (0.02) 0.99 (0.01) 0.96 (0.03)
On_the_go 0.95 (0.04) 0.99 (0.01) 0.96 (0.02)
Talks_excessively 0.95 (0.02) 0.96 (0.01) 0.97 (0.02)
GAD1 restlessness 0.79 (0.07) 0.6411/14 (0.04) 0.339/14 (0.06)
Impulsivity
Blurts_answers 0.96 (0.02) 0.96 (0.01) 0.99 (0.02)
Awaiting_turn 0.97 (0.03) 0.9611/14 (0.01) 0.869/14 (0.04)
Interrupts 0.94 (0.02) 0.99 (0.02) 0.99 (0.03)
Conduct
Bullies 0.81 (0.07) 0.69 (0.11) 0.73 (0.06)
Initiates_fights 0.50 (0.08) 0.60 (0.06) 0.67 (0.07)
Used_weapon 0.64 (0.09) 0.4011/14 (0.1) 0.78 (0.06)
Fire_setting 0.43 (0.1) 0.57 (0.07) 0.60 (0.07)
Property_destruction 0.57 (0.11) 0.7611/14 (0.08) 0.54 (0.07)
Breaks_in 0.879/11 (0.07) 0.59 (0.06) 0.619/14 (0.07)
Lies/cons 0.589/11 (0.08) 0.79 (0.06) 0.809/14 (0.05)
Steals_w/o_confronting 0.78 (0.06) 0.79 (0.05) 0.69 (0.05)
Breaks_curfew 0.41 (0.16)
0.32
b (0.09) 0.49 (0.09)













Sterba et al. Page 13
Age 9–10 Age 11–13 Age 14–16
Estimate (S.E.) Estimate (S.E.) Estimate (S.E.)
Runs_away
0.32
b11/14 (0.09) 0.67 (0.09)
Truant 0.42 (0.12) 0.63 (0.11) 0.46 (0.1)
CD4/5/6/7 parcel 0.45 (0.13) 0.53 (0.09) 0.71 (0.08)
Oppositional Defiant
Loses_temper 0.399/11 (0.08) 0.63 (0.05) 0.709/14 (0.04)
Argues 0.60 (0.08) 0.64 (0.05) 0.73 (0.04)
Actively_defies 0.74 (0.06) 0.82 (0.04) 0.77 (0.04)
Deliberately_annoys 0.70 (0.08) 0.70 (0.05) 0.68 (0.05)
Blames_others 0.58 (0.06) 0.60 (0.05) 0.60 (0.04)
Touchy/annoyed 0.43 (0.09) 0.4211/14 (0.07) 0.649/14 (0.05)
Angry/resentful 0.46 (0.07) 0.6111/14 (0.04) 0.779/14 (0.03)
Spiteful/vindictive 0.52 (0.08) 0.64 (0.05) 0.63 (0.05)
Separation Anxiety
Anticipatory_distress 0.83 (0.06) 0.88 (0.07) 0.81 (0.07)
Worry_loss 0.82 (0.07) 0.65 (0.07) 0.61 (0.08)
Worry_untoward_event 0.78 (0.07) 0.78 (0.12) 0.999/14 (0.07)
School_refusal 0.85 (0.1) 0.67 (0.07) 0.68 (0.08)
Fearful_alone 0.71 (0.12) 0.6611/14 (0.1) 0.92 (0.05)
Sleep_alone 0.48 (0.09) 0.66 (0.08) 0.68 (0.1)
Separation_nightmares 0.819/11 (0.07) 0.52 (0.13) 0.71 (0.12)
Somatic_complaints 0.82 (0.06) 0.76 (0.09) 0.63 (0.09)
Depression/Gen. Anxiety
Restlessness − 0.02† (0.1) 0.1611/14 (0.06) 0.719/14 (0.05)
Concentrating −0.06† (0.09) −0.2211/14 (0.06) 0.11† (0.06)
Irritability 0.67 (0.14) 0.5511/14 (0.09) 0.77 (0.05)
Muscle_tension 0.40 (0.14) 0.5211/14 (0.09) 0.879/14 (0.04)
Sleep_disturbance 0.57 (0.1) 0.52 (0.06) 0.55 (0.05)
Depressed_mood
0.51
c (0.16) 0.73 (0.08) 0.869/14 (0.04)
Anhedonia
0.51
c (0.16) 0.65 (0.17) 0.70 (0.11)
Weight_change 0.33 (0.09) 0.27 (0.06) 0.40 (0.05)
Insomnia/hypersomnia 0.49 (0.11) 0.42 (0.1) 0.64 (0.05)
Psychomotor_agit./retard.
0.51
c (0.16) 0.73 (0.12) 0.929/14 (0.07)
Guilt/worthlessness 0.62 (0.1) 0.73 (0.07) 0.82 (0.04)
Think/decide/concentrate 0.42 (0.14) 0.3011/14 (0.12) 0.70 (0.09)
Suicidal_ideation 0.45 (0.09) 0.4111/14 (0.08) 0.789/14 (0.04)
Fatigue parcel 0.55 (0.13) 0.4411/14 (0.09) 0.70 (0.05)
Social Phobia
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Age 9–10 Age 11–13 Age 14–16
Estimate (S.E.) Estimate (S.E.) Estimate (S.E.)
Fear_social/performance 0.75 (0.14) 0.76 (0.13) 0.99 (0.09)
Exposure_anxiety 0.96 (0.17) 0.98 (0.15) 0.85 (0.08)
Notes.
In each case, the parcel loading is reproduced in this table for each of the constituent symptoms. Items that were parceled at all age blocks are
labeled in the column on the right. A loading significantly different from age 9–10 vs. 11–13 is denoted9/11 for alpha=.05 and9/11 for alpha=.01.
A loading significantly different from age 11–13 to 14–16 at is denoted11/14at alpha=.05 and11/14for alpha=.01. A loading significantly different
from age 9–10 to 14–16 is denoted9/14 at alpha of .05 and9/14 at alpha=.01.
a
These two items parceled at age 9–10.
b
These two items parceled at age 11–13.
c
These three items parceled at age 9–10.
†
Loading not significantly different than 0 at alpha=.05.
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Table 4
Average proportion of variance in DSM symptoms explained by their designated DSM syndrome
Age 9–10 Age 11–13 Age 14–16
Inattention 0.870 0.844 0.868
Hyperactivity 0.905 0.868 0.876
Impulsivity 0.937 0.914 0.894
MDD/GAD 0.382 0.353 0.587
SAD 0.496 0.593 0.584
CD 0.393 0.388 0.427
ODD 0.408 0.319 0.478
SOC 0.769 0.744 0.852
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Table 5
Correlations among latent DSM syndromes in the final age 9–10, 11–13, and 14–16 models.
Factor Correlations Age Differences Correlation 95% CIs
Age 9–10 Age 11–13 Age 14–16 9–10 vs. 11–13 11–13 vs. 14–16 9–10 vs. 14–16 Age 9–10 Age 11–13 Age 14–16
I with H .83* .84* .83* (.71, .90) (.76, .90) (.74, .89)
I with IN .84* .83* .90* (.69, .92) (.72, .91) (.81, .93)
I with ODD .65* .65* .63* (.42, .80) (.54, .75) (.50, .73)
I with CD .66* .48* .40* (.41, .81) (.32, .63) (.27, .52)
I with SAD .10 .28* .43* X (−.10, .29) (.12, .43) (.27, .56)
I with MDD/GAD .49* .39* .26* (.30, .64) (.22, .53) (.14, .39)
I with SOC .27* .04 .22* (.01, .49) (−.14, .21) (0, .41)
H with IN .82* .88* .87* (.68, .91) (.83, .92) (.82, .91)
H with ODD .60* .63* .52* (.44, .72) (.51, .72) (.41, .61)
H with CD .50* .49* .40* (.34, .62) (.34, .62) (.25, .53)
H with SAD .11 .38* .55* X X (−.06, .28) (.25, .49) (.34, .70)
H with MDD/GAD .43* .43* .29* (.22, .60) (.31, .54) (.15, .42)
H with SOC .24* .20* .22* (.02, .44) (.03, .35) (.02, .41)
IN with ODD .61* .50* .60* (.45, .73) (.39, .60) (.51, .68)
IN with CD .60* .46* .41* (.41, .74) (.31, .58) (.29, .52)
IN with SAD .09 .30* .31* X X (−.07, .25) (.18, .40) (.16, .45)
IN with MDD/GAD .48* .44* .30* (.28, .65) (.31, .55) (.18, .41)
IN with SOC .27* .11 .12 (.01, .50) (−.05, .27) (−.05, .29)
ODD with CD .82* .81* .70* (.59, .93) (.70, .88) (.61, .77)
ODD with SAD .05 .27* .35* X X (−.14, .23) (.14, .39) (.17, .51)
ODD with MDD/GAD .54* .63* .57* (.32, .70) (.49, .74) (.45, .66)
ODD with SOC .27 .10 .08 (−.07, .55) (−.08, .27) (−.07, .23)
CD with SAD .41* .27* .40* (.19, .60) (.12, .41) (.20, .56)
CD with MDD/GAD .71* .52* .37* X (.43, .87) (.34, .67) (.25, .47)
CD with SOC .47* .13 −.03 X X (.24, .65) (−.03, .29) (−.24, .18)
SAD with MDD/GAD .58* .63* .68* (.41, .71) (.49, .74) (.47, .81)
SAD with SOC .23 .38* .44* (−.03, .46) (.19, .54) (.15, .66)
MDD/GAD with SOC .41* .30* .56* X (.06, .67) (.07, .49) (.38, .70)
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